Skip to main content

AXA S.A.

SEC CIK
0000898427
Latest filing
Aug 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
675
Value
$344.0K
% of portfolio
0.4%
Quarters held
20
Since Q1 2021
Holdings of REGN by AXA S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026675$344.0K0.4%+322+91.2%AddedHolders
Q1 2026353$272.7K0.1%+353NewHolders
Q3 20250$00.0%−62,430−100.0%Sold outHolders
Q2 202562,430$32.8M0.1%−20,836−25.0%ReducedHolders
Q1 202583,266$52.8M0.2%+2,902+3.6%AddedHolders
Q4 202480,364$57.2M0.2%−6,413−7.4%ReducedHolders
Q3 202486,777$91.2M0.3%−5,877−6.3%ReducedHolders
Q2 202492,654$97.4M0.3%−8,499−8.4%ReducedHolders
Q1 2024101,153$97.4M0.3%−9,324−8.4%ReducedHolders
Q4 2023110,477$97.0M0.3%−3,564−3.1%ReducedHolders
Q3 2023114,041$93.9M0.3%+685+0.6%AddedHolders
Q2 2023113,356$81.5M0.3%−28,381−20.0%ReducedHolders
Q1 2023141,737$116.5M0.4%−26,010−15.5%ReducedHolders
Q4 2022167,747$121.0M0.4%+41,500+32.9%AddedHolders
Q3 2022126,247$87.0M0.3%−4,818−3.7%ReducedHolders
Q2 2022131,065$77.5M0.3%−3,576−2.7%ReducedHolders
Q1 2022134,641$94.0M0.3%−36,434−21.3%ReducedHolders
Q4 2021171,075$108.0M0.3%−26,003−13.2%ReducedHolders
Q3 2021197,078$119.3M0.3%+74,696+61.0%AddedHolders
Q2 2021122,382$68.4M0.2%−15,653−11.3%ReducedHolders
Q1 2021138,035$65.3M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.